Mouse IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT655-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Documentation
Data sheet
Manual
SDS
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
15978

References

Authors, et al. Title Journal Year Volume Pages
Hui Hu Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice Clin Vaccine Immunol 2007 14 894-901
Qiliang Cai Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling Vaccine 2007 25 5155-65
Yanmin Wan Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines Vaccine 2007 25 4949-59
Bing Zhu Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis Eur J Pharm Biopharm 2007 66 318-26
Feng Gao Ex vivo nicotine stimulation augments the efficacy of therapeutic bone marrow-derived dendritic cell vaccination Clin Cancer Res 2007 13 3706-12
Yuxia Zhang Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice Immunology 2007 121 105-12
Hua Yu Selection of SARS-coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on mice Virology 2007 359 264-74
Hai-shan Li Enhancement of DNA vaccine-induced immune responses by a 72-bp element from SV40 enhancer Chin Med J (Engl) 2007 120 496-502
Xianggang Huang Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses Vaccine 2007 25 2620-9
Jiabin Yan Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96 J Gene Med 2007 9 107-21